Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionStrs Ohio
Latest Disclosed Ownership510,771 shares
Latest Disclosed Value $ 71,186,154
Strs Ohio reports 5.63% decrease in ownership of GILD / Gilead Sciences, Inc.

On April 24, 2026 - Strs Ohio filed a 13F-HR form disclosing ownership of 510,771 shares of Gilead Sciences, Inc. (CH:GILD) valued at $71,186,154 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 541,219 shares of Gilead Sciences, Inc.. This represents a change in shares of -5.63% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F GILEAD SCIENCES COM_STK 375558103 510,771 -30,448 -5.63 71,186 7.16 0.2824
2026-02-02 2025-12-31 13F GILEAD SCIENCES COM_STK 375558103 541,219 -17,368 -3.11 66,429 7.14 0.2478
2025-10-30 2025-09-30 13F GILEAD SCIENCES COM_STK 375558103 558,587 24,284 4.54 62,003 4.67 0.2273
2025-08-04 2025-06-30 13F GILEAD SCIENCES COM_STK 375558103 534,303 22,123 4.32 59,238 3.22 0.2212
2025-05-28 2025-03-31 13F GILEAD SCIENCES COM_STK 375558103 512,180 -16,724 -3.16 57,390 17.47 0.2404
2025-05-28 2024-12-31 13F GILEAD SCIENCES COM_STK 375558103 528,904 -10,527 -1.95 48,855 8.02 0.1938
2024-11-01 2024-09-30 13F GILEAD SCIENCES COM_STK 375558103 539,431 -5,071 -0.93 45,226 21.06 0.1740
2024-08-05 2024-06-30 13F GILEAD SCIENCES COM_STK 375558103 544,502 -200 -0.04 37,358 95,689.74 0.1476
2024-05-13 2024-03-31 13F GILEAD SCIENCES COM_STK 375558103 544,702 -52,045 -8.72 40 -18.75 0.1590
2024-01-30 2023-12-31 13F GILEAD SCIENCES COM 375558103 596,747 -32,316 -5.14 48 2.13 0.2012
2023-10-26 2023-09-30 13F/A-1 GILEAD SCIENCES COM 375558103 629,063 -24,399 -3.73 47 -6.00 0.2098
2023-10-26 2023-09-30 13F GILEAD SCIENCES COM 375558103 629,063 -24,399 47 0.2098
2023-07-31 2023-06-30 13F GILEAD SCIENCES COM 375558103 653,462 -36,015 -5.22 50 -12.28 0.2126
2023-08-02 2023-03-31 13F/A-2 GILEAD SCIENCES COM 375558103 689,477 5,521 0.81 57 -1.72 0.2478
2023-08-02 2023-03-31 13F/A-1 GILEAD SCIENCES COM 375558103 689,477 5,521 57 0.2478
2023-04-27 2023-03-31 13F GILEAD SCIENCES COM 375558103 689,477 5,521 57 0.2952
2023-01-26 2022-12-31 13F GILEAD SCIENCES COM 375558103 683,956 -27,672 -3.89 59 -99.87 0.2651
2022-10-27 2022-09-30 13F GILEAD SCIENCES COM 375558103 711,628 731 0.10 43,900 -0.09 0.2092
2022-07-25 2022-06-30 13F GILEAD SCIENCES COM 375558103 710,897 -24,241 -3.30 43,940 0.54 0.1979
2022-04-21 2022-03-31 13F GILEAD SCIENCES COM 375558103 735,138 9,296 1.28 43,703 -17.08 0.1599
2022-01-24 2021-12-31 13F GILEAD SCIENCES COM 375558103 725,842 -9,119 -1.24 52,703 2.66 0.1829
2021-10-22 2021-09-30 13F GILEAD SCIENCES COM 375558103 734,961 -14,995 -2.00 51,337 -0.59 0.1932
2021-07-26 2021-06-30 13F GILEAD SCIENCES COM 375558103 749,956 51,263 7.34 51,641 14.36 0.1857
2021-04-23 2021-03-31 13F GILEAD SCIENCES COM 375558103 698,693 70,487 11.22 45,156 23.38 0.1700
2021-01-25 2020-12-31 13F GILEAD SCIENCES COM 375558103 628,206 -25,105 -3.84 36,599 -11.34 0.1412
2020-12-14 2020-09-30 13F GILEAD SCIENCES COM 375558103 653,311 -47,392 -6.76 41,282 -23.43 0.1729
2020-07-23 2020-06-30 13F GILEAD SCIENCES COM 375558103 700,703 43,143 6.56 53,912 9.67 0.2356
2020-04-23 2020-03-31 13F GILEAD SCIENCES COM 375558103 657,560 -247,314 -27.33 49,159 -16.39 0.2588
2020-01-24 2019-12-31 13F GILEAD SCIENCES COM 375558103 904,874 -43,451 -4.58 58,798 -2.17 0.2463
2019-10-21 2019-09-30 13F/A-1 GILEAD SCIENCES COM 375558103 948,325 -9,119 -0.95 60,104 -7.08 0.2635
2019-10-21 2019-09-30 13F GILEAD SCIENCES COM 375558103 948,325 43,451 60,104 266,023.6375
2019-07-25 2019-06-30 13F GILEAD SCIENCES COM 375558103 957,444 80,171 9.14 64,684 13.42 0.2876
2019-04-19 2019-03-31 13F GILEAD SCIENCES COM 375558103 877,273 -3,551 -0.40 57,031 3.51 0.2585
2019-01-23 2018-12-31 13F GILEAD SCIENCES COM 375558103 880,824 5,165 0.59 55,095 -18.51 0.2797
2018-10-19 2018-09-30 13F GILEAD SCIENCES COM 375558103 875,659 -57,333 -6.15 67,609 2.29 0.2965
2018-08-06 2018-06-30 13F GILEAD SCIENCES COM 375558103 932,992 10,668 1.16 66,093 -4.95 0.2845
2018-04-20 2018-03-31 13F GILEAD SCIENCES COM 375558103 922,324 -437,296 -32.16 69,534 -28.61 0.3075
2018-01-23 2017-12-31 13F GILEAD SCIENCES COM 375558103 1,359,620 -53,070 -3.76 97,403 -14.90 0.4161
2017-10-23 2017-09-30 13F GILEAD SCIENCES COM 375558103 1,412,690 174 0.01 114,456 14.48 0.4914
2017-07-26 2017-06-30 13F GILEAD SCIENCES COM 375558103 1,412,516 -37,090 -2.56 99,977 1.54 0.4454
2017-04-26 2017-03-31 13F GILEAD SCIENCES COM 375558103 1,449,606 -14,556 -0.99 98,457 -6.10 0.4265
2017-01-24 2016-12-31 13F GILEAD SCIENCES COM 375558103 1,464,162 -38,823 -2.58 104,848 -11.83 0.4620
2016-10-27 2016-09-30 13F GILEAD SCIENCES COM 375558103 1,502,985 -8,899 -0.59 118,916 -5.71 0.5312
2016-07-26 2016-06-30 13F GILEAD SCIENCES COM 375558103 1,511,884 -6,674 -0.44 126,121 -9.59 0.5607
2016-04-25 2016-03-31 13F/A-1 GILEAD SCIENCES COM 375558103 1,518,558 8,990 0.60 139,494 -8.68 0.6266
2016-01-28 2015-12-31 13F GILEAD SCIENCES COM 375558103 1,509,568 44 0.00 152,753 3.06 0.6831
2015-10-21 2015-09-30 13F GILEAD SCIENCES COM 375558103 1,509,524 -11,442 -0.75 148,220 -16.76 0.7052
2015-08-04 2015-06-30 13F GILEAD SCIENCES COM 375558103 1,520,966 -166,086 -9.84 178,074 7.57 0.7818
2015-04-27 2015-03-31 13F/A-1 GILEAD SCIENCES COM 375558103 1,687,052 -90,638 -5.10 165,550 -1.20 0.7301
2015-04-21 2015-03-31 13F GILEAD SCIENCES COM 375558103 165,550,413 162,720
2015-01-23 2014-12-31 13F GILEAD SCIENCES COM 375558103 1,777,690 -25,350 -1.41 167,565 -12.70 0.7264
2014-10-29 2014-09-30 13F/A-1 GILEAD SCIENCES COM 375558103 1,803,040 -82,000 -4.35 191,934 22.81 0.8476
2014-10-20 2014-09-30 13F GILEAD SCIENCES COM 375558103 1,803,040 191,934
2014-07-24 2014-06-30 13F GILEAD SCIENCES COM 375558103 1,885,040 -179,265 -8.68 156,289 6.84 0.6965
2014-04-28 2014-03-31 13F GILEAD SCIENCES COM 375558103 2,064,305 -43,700 -2.07 146,277 -7.66 0.6580
2014-01-30 2013-12-31 13F GILEAD SCIENCES COM 375558103 2,108,005 -408,151 -16.22 158,417 0.19 0.7123
2013-10-24 2013-09-30 13F GILEAD SCIENCES COM 375558103 2,516,156 -469,804 -15.73 158,115 3.40 0.6970
2013-08-12 2013-06-30 13F GILEAD SCIENCES COM 375558103 2,985,960 2,985,960 152,911 0.6574
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.